Budapest Open Access Initiative: BOAI Forum Archive[BOAI] [Forum Home] [index] [prev] [next] [options] [help]
[BOAI] filariasis.net - open access to the lymphatic filariasis knowledge base
From: Michael Brown <m.brown AT liverpool.ac.uk>
Dear All, filariasis.net - Open access to the lymphatic filariasis knowledge base... Commonly known as elephantiasis, Lymphatic Filariasis (LF) is caused by thread-like parasitic worms that live in the human lymphatic system. It is one of the world's most disfiguring and debilitating parasitic diseases. Over 120 million people are afflicted in 83 countries, with 20% of the world's population (1.2 billion people) living at risk of the disease. It is a major cause and consequence of poverty, preventing those afflicted from living a normal working & social life. Recently, advances in our understanding of the disease and the availability of safe preventative drug treatments, and new approaches to alleviation of existing symptoms has created an optimism in the scientific and public health community that at last the disease can be eliminated as a public health problem. This task will be accomplished by a global partnership, the Global Alliance for the Elimination of Lymphatic Filariasis (http://www.filariasis.org/), who's formation was catalysed by "the biggest single act of corporate philanthropy in any industry" - the donation by GlaxoSmithKline of Albendazole, (one of the core drugs needed to eliminate this disease), to the programme for as long as it is needed. The Alliance is composed of the ministries of health of the endemic countries, the World Health Organization, GlaxoSmithKline, Merck & Co. Inc., the Lymphatic Filariasis Support Centre at the Liverpool School of Tropical Medicine and tens of other academic and research institutes and Non-Governmental Development Organizations. By eliminating this disease we will prevent the next generation of children being infected & subsequently afflicted. Education and training will play a key role in the success of such an elimination programme, and therefore, the Liverpool Lymphatic Filariasis Support Centre has developed an online knowledge base on lymphatic filariasis, (http://www.filariasis.net), which provides global, free and open access to the most up-to-date teaching and learning resources on this disease, and the programme to eliminate it. For more information on filariasis.net please see Issue 1 of our newsletter below. Best wishes, Mike > Dear Colleague, > > Welcome to issue 1 (May 2003) of filariasis.net Newsletter. > > Before we begin, just a quick note to say if you would like to keep > receiving the monthly filariasis.net Newsletter please reply to > m.brown AT liv.ac.uk with the subject "Subscribe filariasis.net > Newsletter". > If you don't want to receive any further issues you don't need to do > anything - you will be removed from this list automatically. > > So what is filariasis.net? > > filariasis.net - http://www.filariasis.net/ - is a web site dedicated > to > providing free and open access to the lymphatic filariasis knowledge > base > (developed by Mike Brown - m.brown AT liv.ac.uk - at the Liverpool > Lymphatic > Filariasis Support Centre). > > What is available on filariasis.net? > > The article library is now available which includes original > peer-reviewed > research articles and reviews (available as PDFs) from journals such as > the American Journal of Tropical Medicine & Hygiene, Annals of ↵ Tropical > Medicine & Parasitology, Parasitology, Science and Filaria Journal ↵ (see > below for information on the newest content). Over the next few weeks > and > months the site will be expanded extensively with more articles, and > the > Learning Centre will open it's doors with teaching and learning > resources > on all aspects of lymphatic filariasis (- I'll have more news to share > with you on these developments in issue 2 - so subscribe!). > > And finally... > > I would just like to say thanks to all my colleagues, journals, > publishers > and organizations that have helped made filariasis.net a reality, > especially... > > The American Journal of Hygiene & Tropical Medicine, Annals of ↵ Tropical > Medicine & Parasitology & Maney Publishing, Bill & Melinda ↵ Gates > Foundation, Department for International Development and > GlaxoSmithKline. > > Until next month... > > Best wishes, > > Mike > > (P.S. please pass this e-mail on to colleagues you feel maybe > interested > in filariasis.net) > > ================================================================= > > This month on filariasis.net... > > - Article Library > > 1) Supplement: The elimination of lymphatic filariasis: Public health > challenges and the role of vector control > http://www.filariasis.net/article_library/supplements/ > atmp_2002_62_s2.html > > 2) Supplement: Controlling intestinal helminths while eliminating > lymphatic filariasis > http://www.filariasis.net/article_library/supplements/p_2000_121_s.html > > 3) A new insight into the pathogenesis of filarial disease (124KB pdf) > http://www.filariasis.net/article_library/pdfs/cmm/2002/ > cmm_2002_2_299.pdf > > 4) The role of endosymbiotic Wolbachia bacteria in the pathogenesis of > River blindness > http://www.filariasis.net/index.html > > 5) Antibiotics for the treatment of onchocerciasis and other filarial > infections (112KB pdf) > http://www.filariasis.net/article_library/pdfs/coiid/2002/ > coiid_2002_3_53 > 3.p df > > Browse Article Library > http://www.filariasis.net/article_library/index.html > > - Filaria Journal: > > 1) Evidence against Wolbachia symbiosis in Loa loa (308KB pdf) > http://www.filariasis.net/filaria_journal/pdfs/manuscripts/1475-2883- > 2-9. > pdf > > 2) Impact of ivermectin on onchocerciasis transmission. Assessing the > empirical evidence that repeated ivermectin mass treatments may lead to > elimination/eradication in West-Africa (1.1MB pdf) > http://www.filariasis.net/filaria_journal/pdfs/manuscripts/1475-2883- > 2-8. > pdf > > 3) Mapping of lymphatic filariasis in Nepal (856KB pdf) > http://www.filariasis.net/filaria_journal/pdfs/manuscripts/1475-2883- > 2-7. > pdf > > 4) Human immune responses to infective stage larval-specific chitinase > of > filarial parasite, Onchocerca volvulus, Ov-CHI-1 (456KB pdf) > http://www.filariasis.net/filaria_journal/pdfs/manuscripts/1475-2883- > 2-6. > pdf > > 5) Some observations on the effect of Daflon (micronized purified > flavonoid fraction of Rutaceae aurantiae) in bancroftian filarial > lymphoedema (284KB pdf) > http://www.filariasis.net/filaria_journal/pdfs/manuscripts/1475-2883- > 2-5. > pdf > > 6) Lymphoedema: Pathophysiology and Management in resource poor > Settings > relevance for lymphatic filariasis control programmes (256KB pdf) > http://www.filariasis.net/filaria_journal/pdfs/manuscripts/1475-2883- > 2-4. > pdf > > Browse Filaria Journal mirror site > http://www.filariasis.net/filaria_journal/index.html > > ================================================================= > > - Submissions > > Send all submissions, be it a resource you want to make available, an > idea > for a resource and/or news & event information to m.brown AT ↵ liv.ac.uk. > > - Feedback > > We welcome your feedback on any aspect of filariasis.net. Please tell > us > what you like, and what you dislike. As usual the address is > m.brown AT liv.ac.uk > > - Subscribing to filariasis.net Newsletter > > To subscribe send an e-mail to m.brown AT liv.ac.uk, with the subject > "Subscribe filariasis.net Newsletter" > > - Unsubscribing from filariasis.net Newsletter > > To unsubscribe send an e-mail to m.brown AT liv.ac.uk, with the subject > "Unsubscribe filariasis.net Newsletter". You will be removed > immediately > from the list. > > - Privacy > > n: the quality of being secluded from the presence or view of others. > > Your e-mail address will only be used to send you information from > filariasis.net. > > ================================================================= > > filariasis.net - Open access to the lymphatic filariasis knowledge base > > http://www.filariasis.net/
[BOAI] [Forum Home] [index] [prev] [next] [options] [help]
E-mail: firstname.lastname@example.org .